Log In
Print this Print this

TransCyte (formerly Dermagraft-TC)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionEngineered human dermis with synthetic epidermis
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationBurns
Indication DetailsAlternative to cadaver skin to cover wounds until skin is available for grafting; Alternative to human cadaver skin as a transitional covering in patients with severe burns; Cover burns until enough of patients' skin is available for grafting; Cover severe burns until a patient's own skin is available for grafting; Temporary covering for burns; Treat second-degree burns; Treat severe thermal burns
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today